The efficiency and safety of low-dose apatinib combined with oral vinorelbine in pretreated HER2-negative metastatic breast cancer

CONCLUSION: Low-dose apatinib combined with oral vinorelbine demonstrates potential efficacy and well tolerated for pretreated HER2-negative mBC.PMID:38659376 | DOI:10.1002/cam4.7181

Source: Cancer Control - April 25, 2024 Category: Cancer & Oncology Authors: Jia-Yi Huang Xue-Lian Chen Xiao-Feng Xie Lin Song Li-Ping Chen Xiao-Feng Lan Xue Bai Xiao Chen Cai-Wen Du Source Type: research